These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16546982)

  • 1. Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene.
    Li X; Raikwar SP; Liu YH; Lee SJ; Zhang YP; Zhang S; Cheng L; Lee SD; Juliar BE; Gardner TA; Jeng MH; Kao C
    Mol Cancer Ther; 2006 Mar; 5(3):676-84. PubMed ID: 16546982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy.
    Li X; Liu YH; Lee SJ; Gardner TA; Jeng MH; Kao C
    Clin Cancer Res; 2008 Jan; 14(1):291-9. PubMed ID: 18172281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model.
    Raikwar SP; Temm CJ; Raikwar NS; Kao C; Molitoris BA; Gardner TA
    Mol Ther; 2005 Dec; 12(6):1091-100. PubMed ID: 16169279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases.
    Zhao P; Luo R; Wu J; Xie F; Li H; Xiao X; Fu L; Zhu X; Liu R; Zhu Y; Liang Z; Huang W
    J Cell Mol Med; 2010 Jan; 14(1-2):381-91. PubMed ID: 26065034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas ligand delivery by a prostate-restricted replicative adenovirus enhances safety and antitumor efficacy.
    Li X; Liu YH; Zhang YP; Zhang S; Pu X; Gardner TA; Jeng MH; Kao C
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5463-73. PubMed ID: 17875776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of angiostatin K1-3 and endostatin genes coadministered by the hydrodynamics-based transfection method.
    Kim KS; Park YS
    Oncol Res; 2005; 15(7-8):343-50. PubMed ID: 16491952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model.
    Isayeva T; Chanda D; Kallman L; Eltoum IE; Ponnazhagan S
    Cancer Res; 2007 Jun; 67(12):5789-97. PubMed ID: 17575146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer.
    Tysome JR; Wang P; Alusi G; Briat A; Gangeswaran R; Wang J; Bhakta V; Fodor I; Lemoine NR; Wang Y
    Hum Gene Ther; 2011 Sep; 22(9):1101-8. PubMed ID: 21361787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor.
    Ponnazhagan S; Mahendra G; Kumar S; Shaw DR; Stockard CR; Grizzle WE; Meleth S
    Cancer Res; 2004 Mar; 64(5):1781-7. PubMed ID: 14996740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An oncolytic adenovirus enhances antiangiogenic and antitumoral effects of a replication-deficient adenovirus encoding endostatin by rescuing its selective replication in nasopharyngeal carcinoma cells.
    Liu RY; Zhou L; Zhang YL; Huang BJ; Ke ML; Chen JM; Li LX; Fu X; Wu JX; Huang W
    Biochem Biophys Res Commun; 2013 Dec; 442(3-4):171-6. PubMed ID: 24269822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting prostate cancer with conditionally replicative adenovirus using PSMA enhancer.
    Lee SJ; Zhang Y; Lee SD; Jung C; Li X; Kim HS; Bae KH; Jeng MH; Kao C; Gardner T
    Mol Ther; 2004 Dec; 10(6):1051-8. PubMed ID: 15564137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer.
    Tysome JR; Briat A; Alusi G; Cao F; Gao D; Yu J; Wang P; Yang S; Dong Z; Wang S; Deng L; Francis J; Timiryasova T; Fodor I; Lemoine NR; Wang Y
    Gene Ther; 2009 Oct; 16(10):1223-33. PubMed ID: 19587709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
    Isayeva T; Ren C; Ponnazhagan S
    Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
    Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL
    Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes.
    Kim KS; Kim DS; Chung KH; Park YS
    Cancer Gene Ther; 2006 Jun; 13(6):563-71. PubMed ID: 16410825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer.
    Li X; Zhang YP; Kim HS; Bae KH; Stantz KM; Lee SJ; Jung C; Jiménez JA; Gardner TA; Jeng MH; Kao C
    Cancer Res; 2005 Mar; 65(5):1941-51. PubMed ID: 15753394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective gene-viral therapy for telomerase-positive cancers by selective replicative-competent adenovirus combining with endostatin gene.
    Zhang Q; Nie M; Sham J; Su C; Xue H; Chua D; Wang W; Cui Z; Liu Y; Liu C; Jiang M; Fang G; Liu X; Wu M; Qian Q
    Cancer Res; 2004 Aug; 64(15):5390-7. PubMed ID: 15289347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of B16BL6 tumor progression by coadministration of recombinant angiostatin K1-3 and endostatin genes with cationic liposomes.
    Kim KS; Kim HS; Park JS; Kwon YG; Park YS
    Cancer Gene Ther; 2004 Jun; 11(6):441-9. PubMed ID: 15118757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.